Drug
Zulresso
Zulresso: highest development phase Post-Market, developed by Supernus Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Supernus Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZULRESSO® NCT05059600 | Post-Market | Postpartum Depression |
Latest
No recent events.
Follow Zulresso on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.